Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Gross Profit: 2020-2025

Historic Gross Profit for Relay Therapeutics (RLAY) over the last 3 years, with Jun 2025 value amounting to $677,000.

  • Relay Therapeutics' Gross Profit was N/A to $677,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $18.4 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2024, which is 60.83% down from last year.
  • Per Relay Therapeutics' latest filing, its Gross Profit stood at $677,000 for Q2 2025, which was down 91.18% from $7.7 million recorded in Q1 2025.
  • In the past 5 years, Relay Therapeutics' Gross Profit ranged from a high of $25.2 million in Q3 2023 and a low of -$1,000 during Q4 2023.
  • Its 3-year average for Gross Profit is $6.3 million, with a median of $677,000 in 2025.
  • Per our database at Business Quant, Relay Therapeutics' Gross Profit surged by 13,420.00% in 2021 and then plummeted by 100.40% in 2023.
  • Over the past 5 years, Relay Therapeutics' Gross Profit (Quarterly) stood at $567,000 in 2021, then tumbled by 55.38% to $253,000 in 2022, then tumbled by 100.40% to -$1,000 in 2023, then skyrocketed by 4,327.88% to $10.0 million in 2024, then declined by 23.26% to $677,000 in 2025.
  • Its Gross Profit stands at $677,000 for Q2 2025, versus $7.7 million for Q1 2025 and $10.0 million for Q1 2024.